Skip to main content

Animations

MJFF Publications

1401 - 1410 of 8471 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00497-x
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6
    Citation Count: 397
  • Summary Details
    RESTRICTED
    Title: Brain Structure Ages -- A new biomarker for multi-disease classification
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.48550/arxiv.2304.06591
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohorts
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0282684
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord
    Journal Name: Pharmaceutics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/pharmaceutics15041230
    Citation Count: 8
  • Summary Details
    OPEN
    Title: USP8 Down-Regulation Promotes Parkin-Independent Mitophagy in the Drosophila Brain and in Human Neurons
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12081143
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschembio.2c00868
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental Sciences
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1138546
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1155669
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.